Sagimet Biosciences (SGMT) Other Non Operating Income (2022 - 2026)

Sagimet Biosciences' Other Non Operating Income history runs 5 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• On a quarterly basis, Other Non Operating Income fell 37.06% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $5.2 million, a 38.07% decrease from a year earlier, with the FY2025 full-year figure at $5.9 million, down 34.16% from the prior year.
• Other Non Operating Income retreated to $1.1 million in Q1 2026 per SGMT's latest filing, from $1.2 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $2.5 million in Q2 2024 and bottomed at $136000.0 in Q2 2022.
• The 5-year median for Other Non Operating Income is $1.3 million (2023), against an average of $1.2 million.
• Across the five-year window, Other Non Operating Income jumped 1101.69% in 2024 and plunged 39.97% in 2025, its largest moves.
• Year by year, Other Non Operating Income stood at $193000.0 in 2022, then soared by 581.35% to $1.3 million in 2023, then surged by 51.63% to $2.0 million in 2024, then tumbled by 39.97% to $1.2 million in 2025, then retreated by 11.19% to $1.1 million in 2026.
• Per Business Quant, the three latest SGMT Other Non Operating Income figures stand at $1.1 million (Q1 2026), $1.2 million (Q4 2025), and $1.4 million (Q3 2025).